Cargando…
Liver safety of two nucleoside analogs plus efavirenz, nevirapine or a ritonavir-boosted protease inhibitor in HIV/HCV-coinfected drug-naïve patients
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The International AIDS Society
2010
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3113099/ http://dx.doi.org/10.1186/1758-2652-13-S4-P91 |
| _version_ | 1782205887617695744 |
|---|---|
| author | Macías, J Mallolas, J López-Cortés, LF Cartón, JA Domingo, P Moreno, S Iribarren, JA Neukam, K Rodrigo, A Jiménez-Expósito, MJ Pineda, JA |
| author_facet | Macías, J Mallolas, J López-Cortés, LF Cartón, JA Domingo, P Moreno, S Iribarren, JA Neukam, K Rodrigo, A Jiménez-Expósito, MJ Pineda, JA |
| author_sort | Macías, J |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-3113099 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2010 |
| publisher | The International AIDS Society |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-31130992011-06-13 Liver safety of two nucleoside analogs plus efavirenz, nevirapine or a ritonavir-boosted protease inhibitor in HIV/HCV-coinfected drug-naïve patients Macías, J Mallolas, J López-Cortés, LF Cartón, JA Domingo, P Moreno, S Iribarren, JA Neukam, K Rodrigo, A Jiménez-Expósito, MJ Pineda, JA J Int AIDS Soc Poster Presentation The International AIDS Society 2010-11-08 /pmc/articles/PMC3113099/ http://dx.doi.org/10.1186/1758-2652-13-S4-P91 Text en Copyright ©2010 Macías et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Poster Presentation Macías, J Mallolas, J López-Cortés, LF Cartón, JA Domingo, P Moreno, S Iribarren, JA Neukam, K Rodrigo, A Jiménez-Expósito, MJ Pineda, JA Liver safety of two nucleoside analogs plus efavirenz, nevirapine or a ritonavir-boosted protease inhibitor in HIV/HCV-coinfected drug-naïve patients |
| title | Liver safety of two nucleoside analogs plus efavirenz, nevirapine or a ritonavir-boosted protease inhibitor in HIV/HCV-coinfected drug-naïve patients |
| title_full | Liver safety of two nucleoside analogs plus efavirenz, nevirapine or a ritonavir-boosted protease inhibitor in HIV/HCV-coinfected drug-naïve patients |
| title_fullStr | Liver safety of two nucleoside analogs plus efavirenz, nevirapine or a ritonavir-boosted protease inhibitor in HIV/HCV-coinfected drug-naïve patients |
| title_full_unstemmed | Liver safety of two nucleoside analogs plus efavirenz, nevirapine or a ritonavir-boosted protease inhibitor in HIV/HCV-coinfected drug-naïve patients |
| title_short | Liver safety of two nucleoside analogs plus efavirenz, nevirapine or a ritonavir-boosted protease inhibitor in HIV/HCV-coinfected drug-naïve patients |
| title_sort | liver safety of two nucleoside analogs plus efavirenz, nevirapine or a ritonavir-boosted protease inhibitor in hiv/hcv-coinfected drug-naïve patients |
| topic | Poster Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3113099/ http://dx.doi.org/10.1186/1758-2652-13-S4-P91 |
| work_keys_str_mv | AT maciasj liversafetyoftwonucleosideanalogsplusefavirenznevirapineoraritonavirboostedproteaseinhibitorinhivhcvcoinfecteddrugnaivepatients AT mallolasj liversafetyoftwonucleosideanalogsplusefavirenznevirapineoraritonavirboostedproteaseinhibitorinhivhcvcoinfecteddrugnaivepatients AT lopezcorteslf liversafetyoftwonucleosideanalogsplusefavirenznevirapineoraritonavirboostedproteaseinhibitorinhivhcvcoinfecteddrugnaivepatients AT cartonja liversafetyoftwonucleosideanalogsplusefavirenznevirapineoraritonavirboostedproteaseinhibitorinhivhcvcoinfecteddrugnaivepatients AT domingop liversafetyoftwonucleosideanalogsplusefavirenznevirapineoraritonavirboostedproteaseinhibitorinhivhcvcoinfecteddrugnaivepatients AT morenos liversafetyoftwonucleosideanalogsplusefavirenznevirapineoraritonavirboostedproteaseinhibitorinhivhcvcoinfecteddrugnaivepatients AT iribarrenja liversafetyoftwonucleosideanalogsplusefavirenznevirapineoraritonavirboostedproteaseinhibitorinhivhcvcoinfecteddrugnaivepatients AT neukamk liversafetyoftwonucleosideanalogsplusefavirenznevirapineoraritonavirboostedproteaseinhibitorinhivhcvcoinfecteddrugnaivepatients AT rodrigoa liversafetyoftwonucleosideanalogsplusefavirenznevirapineoraritonavirboostedproteaseinhibitorinhivhcvcoinfecteddrugnaivepatients AT jimenezexpositomj liversafetyoftwonucleosideanalogsplusefavirenznevirapineoraritonavirboostedproteaseinhibitorinhivhcvcoinfecteddrugnaivepatients AT pinedaja liversafetyoftwonucleosideanalogsplusefavirenznevirapineoraritonavirboostedproteaseinhibitorinhivhcvcoinfecteddrugnaivepatients |